Aim. To study the awareness of graduate pharmacy students with the concept of the “rational use of medicines” and related issues. Materials and methods. A questionnaire survey of 172 graduate students was conducted at the National University of Pharmacy. Results and discussion. Most students believe that they are clearly familiar with the concept of the “rational use of medicines”; 97.1 % of them know it from the disciplines they studied at the University. It has been found that students have both correct and erroneous ideas about the mandatory principles of the rational use of medicines; they are most aware of its clinical aspects. Not all signs of the irrational use of medicines are obvious for future pharmacists. Students possess certain skills that can be useful in promoting the rational use of medicines. However, not all acquired skills are in demand in the professional activities of pharmacists in Ukraine. 75.6% of respondents think their knowledge gained at the University is sufficient to promote the rational use of medicines. Only 48.3 % of respondents believe that Ukrainian pharmacists are sufficiently involved in promoting the rational use of medicines. Conclusions. The study has revealed the lack of awareness of some pharmaceutical students about the concept and problem of the rational use of medicines, as well as the gap between the acquired skills and their demand in professional activities. Less than half of students rate the role of pharmacists in promoting the rational use of medicines at a sufficient level. Further research will be aimed at developing measures to improve the awareness of pharmacy students with the basic concepts of the rational use of medicines, as well as expanding the participation of Ukrainian pharmacists in promoting the rational use of medicines.
Goal is an analysis of the assortment of anti-inflammatory and anti-rheumatic medicines presented on the pharmaceutical market of Ukraine, and substantiation of market opportunities for domestic manufacturers. Materials and methods. The research materials are data from the State Register of Medicines of Ukraine and the online directory of medicines Compendium, publications of scientific and practically-oriented medical and pharmaceutical publications. The methods of office marketing research, comparative analysis, logical summarization of results, and the graphic method were used for achieving the goal. Results of the research. During the study, the structure of the assortment of anti-inflammatory and anti-rheumatic medicines and the characteristic trends for the registration of new medicines on the domestic pharmaceutical market were determined. It has been established that in 2022, 463 trade names will be registered on the domestic pharmaceutical market. The assortment of anti-inflammatory and anti-rheumatic medicines was analyzed by active substance, release form, producing countries, and the possibility of use in pediatrics. Prospective directions for updating the product assortment of anti-inflammatory and anti-rheumatic medicines of domestic production have been determined. Conclusions. According to the results of the study, it was found that the group of anti-inflammatory and anti-rheumatic medicines is represented by a wide assortment, however, the market is characterized by import dependence, which has a negative impact on the medical supply of certain categories of consumers. Prospective segments on the market of anti-inflammatory and anti-rheumatic medicines for domestic manufacturers have been established.
Aim. To study and assess the components of the trademark complex, as well as to determine the market power of anti-allergic drugs on the example of Cetirizine. Materials and methods. Scientific publications, reports of the State Statistics Committee of Ukraine and the Center for Medical Statistics of the Ministry of Health of Ukraine, the results of monitoring the retail pharmaceutical market of the “Pharmastandard” system of the “Morion” company, the results of the own research, as well as methods of content and marketing analysis, statistical processing were used as materials. Results. The necessity of further development and deepening of studies of the components of the complex of trademarks (TM) of drugs, changes of market positions of drugs within TM and its highest brand level has been substantiated. It has been recommended to include the notion of “confidence” to the manufacturer and a specific drug to the qualitative consumer characteristics; this notion acts as an indicator of the future strengthening of the drug market positions. On the example of ten drugs of Cetirizine, the assessment of consumer and market indicators of market power of ten drugs based on Cetirizen has been done using a questionnaire survey. A scale of values of the characteristics of the market positions of the TM Cetirizine complex has been developed, and the state of TM and brands at five levels of each has been assessed. The distribution of ten drugs of Cetirizine has been done in the conventional competitive environment using the marketing map. Ten areas of market positions of the TM complex and brands have been identified. The assessment of individual components of TM, which characterize the market power of Cetirizine antiallergic drugs has been performed. Conclusions. Consumer and market indicators of the market power of drugs based on Cetirizine have been characterized. It has been recommended to include the notion of “confidence” to the manufacturer and a specific drug to the consumer characteristics of the TM complex. Based on the questionnaire survey of respondents, single and generalized indicators of ten drugs of Cetirizine have been determined, their levels have been calculated, and a scale of values of the market power characteristics of the TM drug complex has been developed. The state of TM and brands of Cetirizine drugs have been assessed by five levels ranging from absence to a very strong market position. The levels of TM of Cetirizine drugs have been assessed using the scale of values. By using the marketing map the TM distribution of ten drugs of Cetirizine has been done in the competitive market environment, and the areas of market positions have been identified. The components of the TM complex that characterize the market power of drugs based on Cetirizine have been assessed.
Aim. To substantiate the methodological approach and work out the method for determining economic and marketing components of the cost price, the price and the added value of the drug on the example of Rabeprazole. Materials and methods. Scientific publications, reports of the State Statistics Committee of Ukraine and Centre for Medical Statistics of the MHU, reports and calculations of the cost price of pharmaceutical manufacturers, our own research, as well as methods of systematic, comparative, content-analysis, economic and marketing analysis were used as materials. Results. The stages of work have been summarized, and the algorithm for determining the basic indicators required for manufacturing of drugs has been formed. An extended scheme of calculation of the cost price of products based on the economic approach has been developed; the formation of retail and wholesale price and determination of the wholesale sale value of the drug on the basis of the marketing approach have been studied. The method for determining the basic economic indicators according to the market economic approach, calculation of the added value tax, income and profitability has been worked out on the example of rabeprazole. The distribution of the added value among the subjects of drug promotion and the structure of the added value of the manufacturer have been estimated. Conclusions. The expediency and the necessity of using economic and marketing approaches of the cost management has been substantiated. The cost price and the formation of price for a drug has been calculated, and themethodological approach has been suggested. To assess the total market economic approach as to the determination of the cost price and the price of drug, a graphic scheme of economic and marketing approaches for determining the cost price and the price of drug (progressive retrograde calculation) has been developed. On the example of rabeprazole tablets (0.01 g) the method for determining the cost price, the price, the income and the added value of a drug manufacturer, wholesaler and pharmacy has been studied. The structure of the added value of the drug manufacturer has been characterized.
Мета полягає у дослідженні, узагальненні та розробленні напрямів взаємного співробітництва закладу вищої освіти (ЗВО) з роботодавцями фармацевтичного сектору галузі охорони здоров'я, що надасть можливість здійснювати підготовку конкурентоспроможних компетентних фахівців відповідно до вимог ринку праці. Методи: Для досягнення мети використано методи наукового аналізу, зокрема узагальнення, порівняння, системний та логічний методи. Для наочного представлення узагальнених результатів експертного опитування застосовано графічний аналіз. Результати: Обґрунтовано науково-практичні підходи до визначення напрямів взаємного співробітництва ЗВО з роботодавцями фармацевтичного сектору галузі охорони здоров'я. Наведено сучасні напрями співробітництва закладу вищої освіти з роботодавцями, які сприяють удосконаленню організаційно-методичних засад взаємодії, оптимізації змісту освіти та освітнього процесу, пі двищенню якості практичної підготовки та працевлаштування випускників, розвитку науководослідної діяльності та інноваційної інфраструктури. Систематизовано форми співпраці Націон ального фармацевтичного університету (НФаУ) з аптечними закладами та фармацевтичними під приємствами, впровадження яких дозволить підвищити якість практичної підготовки фахівців фармації. Висновки: На підставі результатів експертного опитування фахівців фармації визначено, що на йбільш вагомими мотивами співпраці Національного фармацевтичного університету з роб отодавцями фармацевтичного сектору галузі охорони здоров'я є підготовка фахівців відповідно до потреб підприємств і доступ до кваліфікованих трудових ресурсів, а ефективними формами співробітни цтва-наставництво і тренінги. За результатами дослідження особливостей та форм співпраці авторами виконано їх систематизацію і визначено напрями взаємного співробітництва ЗВО з р оботодавцями на прикладі НФаУ, реалізація яких сприяє підвищенню якості практичної підготовки майбутніх фахівців фармації та формуванню конкурентоспроможних випускників відповідно до вимог ринку праці.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.